Mesenchymal Stem Cells Clinical Trial
Official title:
Phase I/II Randomized Controlled Trial of Umbilical Cord-derived mesenChymAl stRomal cElls in Systemic Sclerosis
The purpose of this study is to test the safety and efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (UCMSC) for the treatment of Systemic Sclerosis (SSc).
A single-center, three-arm, randomized, double-blind, placebo-controlled trial is proposed. A total of 18 SSc patients will be enrolled in 3 successive blocks of 6 patients each. After being informed about the study and potential risks, all patients giving written informed consent will be randomized to one of two treatment arms or a placebo arm (total of 6 patients per arm). Within each block, the 6 patients will be randomized in a 2:2:2 ratio in one of the following arms: placebo, 1 infusion of UCMSC (M0), or 2 infusions of UCMSC (M0, M3). Second infusions of UCMSC will be performed only in the absence of Treatment Related Severe Adverse Events (TRSAE). Randomization into blocks 2 and 3 will be staggered, to allow the detection of TRSAE prior to inclusion of patients in a subsequent block, i.e. the second block will be randomized only in the absence of TRSAE one month after the first infusion of all 6 patients in block one, and similarly for the third block. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01219465 -
Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01221428 -
Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis
|
Phase 1/Phase 2 | |
Completed |
NCT03105284 -
Adipose-tissue Derived Stem Cells in Flaps Versus Liposuction
|
N/A | |
Not yet recruiting |
NCT01224327 -
Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients
|
Phase 1/Phase 2 | |
Recruiting |
NCT06149832 -
Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing
|
Phase 4 | |
Recruiting |
NCT05165459 -
Open Label Single Arm Proof of Concept Trial to Evaluate the Efficacy and Safety of Cytori Celution System in Chronic Non-Healing Venous Leg Ulcers
|
N/A | |
Active, not recruiting |
NCT04014166 -
Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia
|
N/A | |
Not yet recruiting |
NCT06077734 -
Muscle Stem Cell Quality in Atrophy
|
||
Completed |
NCT00956891 -
Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation
|
Phase 1/Phase 2 | |
Recruiting |
NCT01218464 -
Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03874572 -
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth
|
Phase 1 | |
Recruiting |
NCT00953485 -
Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04863183 -
Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis
|
Phase 1/Phase 2 | |
Completed |
NCT06360861 -
Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1 | |
Completed |
NCT05018754 -
Treatment of Oral Mucositis Using Platelet Rich Fibrin TREATMENT OF ORAL MUCOSITIS USING PRF
|
||
Completed |
NCT03130374 -
Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02673788 -
Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage
|
||
Recruiting |
NCT01763099 -
Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure
|
Phase 2 | |
Recruiting |
NCT01763086 -
Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant
|
Phase 2 | |
Completed |
NCT02302599 -
Mesenchymal Stem Cells to Treat Type 2 Diabetes
|
Phase 2 |